Pharmacoeconomic analysis of cost-benefit in evaluating the effectiveness of treatment for epilepsy in adults

Abstract

The investigation evaluated the clinicoeconomic benefits of epilepsy therapy performed by a district neurologist versus an epileptologist in the outpatient setting. The index «cost-benefit» was calculated for different types of epileptic seizures in employed and unemployed patients before and after therapy optimization. Even if there was a considerable increase in direct costs after correction of antiepileptic therapy, the cost of patient management was shown to decrease by 2-3 times on average irrespective of the type of a seizure.

Keywords

• adult epilepsy
• pharmacoeconomic analysis
• cost-benefit
• antiepileptics